BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 35388085)

  • 1. Identification of allosteric fingerprints of alpha-synuclein aggregates in matrix metalloprotease-1 and substrate-specific virtual screening with single molecule insights.
    Kamboj S; Harms C; Wright D; Nash A; Kumar L; Klein-Seetharaman J; Sarkar SK
    Sci Rep; 2022 Apr; 12(1):5764. PubMed ID: 35388085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allosteric Communications between Domains Modulate the Activity of Matrix Metalloprotease-1.
    Kumar L; Nash A; Harms C; Planas-Iglesias J; Wright D; Klein-Seetharaman J; Sarkar SK
    Biophys J; 2020 Jul; 119(2):360-374. PubMed ID: 32585130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity-dependent interdomain dynamics of matrix metalloprotease-1 on fibrin.
    Kumar L; Planas-Iglesias J; Harms C; Kamboj S; Wright D; Klein-Seetharaman J; Sarkar SK
    Sci Rep; 2020 Nov; 10(1):20615. PubMed ID: 33244162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Environmental and genetic factors support the dissociation between α-synuclein aggregation and toxicity.
    Villar-Piqué A; Lopes da Fonseca T; Sant'Anna R; Szegö ÉM; Fonseca-Ornelas L; Pinho R; Carija A; Gerhardt E; Masaracchia C; Abad Gonzalez E; Rossetti G; Carloni P; Fernández CO; Foguel D; Milosevic I; Zweckstetter M; Ventura S; Outeiro TF
    Proc Natl Acad Sci U S A; 2016 Oct; 113(42):E6506-E6515. PubMed ID: 27708160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scaffold-based Screening and Molecular Dynamics Simulation Study to Identify Two Structurally Related Phenolic Compounds as Potent MMP1 Inhibitors.
    Patra S; Saravanan P; Das B; Subramanian V; Patra S
    Comb Chem High Throughput Screen; 2020; 23(8):757-774. PubMed ID: 32342802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endosulfine-alpha inhibits membrane-induced α-synuclein aggregation and protects against α-synuclein neurotoxicity.
    Ysselstein D; Dehay B; Costantino IM; McCabe GP; Frosch MP; George JM; Bezard E; Rochet JC
    Acta Neuropathol Commun; 2017 Jan; 5(1):3. PubMed ID: 28069058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different Effects of α-Synuclein Mutants on Lipid Binding and Aggregation Detected by Single Molecule Fluorescence Spectroscopy and ThT Fluorescence-Based Measurements.
    Ruf VC; Nübling GS; Willikens S; Shi S; Schmidt F; Levin J; Bötzel K; Kamp F; Giese A
    ACS Chem Neurosci; 2019 Mar; 10(3):1649-1659. PubMed ID: 30605594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Selective Novel Hits against
    Nyamai DW; Tastan Bishop Ö
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32471245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of the novel A53E alpha-synuclein mutation on its oligomerization and aggregation.
    Lázaro DF; Dias MC; Carija A; Navarro S; Madaleno CS; Tenreiro S; Ventura S; Outeiro TF
    Acta Neuropathol Commun; 2016 Dec; 4(1):128. PubMed ID: 27938414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advancements in a FRET Biosensor for Live-Cell Fluorescence-Lifetime High-Throughput Screening of Alpha-Synuclein.
    Braun AR; Kochen NN; Yuen SL; Liao EE; Cornea RL; Thomas DD; Sachs JN
    ASN Neuro; 2023; 15():17590914231184086. PubMed ID: 37428128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lewy body-associated proteins: victims, instigators, or innocent bystanders? The case of AIMP2 and alpha-synuclein.
    Lashuel HA; Novello S
    Neurobiol Dis; 2021 Aug; 156():105417. PubMed ID: 34102275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two C-terminal sequence variations determine differential neurotoxicity between human and mouse α-synuclein.
    Landeck N; Strathearn KE; Ysselstein D; Buck K; Dutta S; Banerjee S; Lv Z; Hulleman JD; Hindupur J; Lin LK; Padalkar S; Stanciu LA; Lyubchenko YL; Kirik D; Rochet JC
    Mol Neurodegener; 2020 Sep; 15(1):49. PubMed ID: 32900375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thermodynamic Basis of Selectivity in the Interactions of Tissue Inhibitors of Metalloproteinases N-domains with Matrix Metalloproteinases-1, -3, and -14.
    Zou H; Wu Y; Brew K
    J Biol Chem; 2016 May; 291(21):11348-58. PubMed ID: 27033700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolyl oligopeptidase inhibition reduces alpha-synuclein aggregation in a cellular model of multiple system atrophy.
    Cui H; Kilpeläinen T; Zouzoula L; Auno S; Trontti K; Kurvonen S; Norrbacka S; Hovatta I; Jensen PH; Myöhänen TT
    J Cell Mol Med; 2021 Oct; 25(20):9634-9646. PubMed ID: 34486218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha synuclein processing by MMP-3 - implications for synucleinopathies.
    Bluhm A; Schrempel S; Moceri S; Stieler J; Feja M; Schilling S; Schulze A; von Hörsten S; Hartlage-Rübsamen M; Richter F; Roßner S
    Behav Brain Res; 2022 Sep; 434():114020. PubMed ID: 35870616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small-angle neutron scattering reveals the assembly of alpha-synuclein in lipid membranes.
    Anunciado D; Rai DK; Qian S; Urban V; O'Neill H
    Biochim Biophys Acta; 2015 Dec; 1854(12):1881-1889. PubMed ID: 26321599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hsp70 chaperone blocks α-synuclein oligomer formation via a novel engagement mechanism.
    Tao J; Berthet A; Citron YR; Tsiolaki PL; Stanley R; Gestwicki JE; Agard DA; McConlogue L
    J Biol Chem; 2021; 296():100613. PubMed ID: 33798554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-seeding of alpha-synuclein aggregation by amyloid fibrils of food proteins.
    Vaneyck J; Segers-Nolten I; Broersen K; Claessens MMAE
    J Biol Chem; 2021; 296():100358. PubMed ID: 33539920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characterization of an aggregation-prone variant of alpha-synuclein used to model synucleinopathies.
    Masaracchia C; König A; Valiente-Gabioud AA; Peralta P; Favretto F; Strohäker T; Lázaro DF; Zweckstetter M; Fernandez CO; Outeiro TF
    Biochim Biophys Acta Proteins Proteom; 2020 Jan; 1868(1):140298. PubMed ID: 31676453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-terminal acetylation mutants affect alpha-synuclein stability, protein levels and neuronal toxicity.
    Vinueza-Gavilanes R; Íñigo-Marco I; Larrea L; Lasa M; Carte B; Santamaría E; Fernández-Irigoyen J; Bugallo R; Aragón T; Aldabe R; Arrasate M
    Neurobiol Dis; 2020 Apr; 137():104781. PubMed ID: 31991248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.